Watch our Industry User Meeting from SNMMI's 2021 Annual Meeting!

We are an emerging leader with new solutions in the field of nuclear medicine technology

Our innovative products and technologies are designed to meet current and future demands for medical radioisotopes. They mark a new era for nuclear medicine technology.

Discover our Products

Supply

Medical radioisotopes are critical to meet patient healthcare needs and advance clinical research. We’ve charted the course for producing a stable, reliable and domestically sourced isotope supply.

Explore our Processes

Commitment

Our people drive our solutions. From providing domestic supply of isotopes for patients to national security and environmental sustainability, we are committed to advancing radioisotope technology to shape a better world.

Learn More

About NorthStar

We are a nuclear medicine technology company committed to providing the United States with stable, domestic and environmentally friendly radioisotope supply solutions to meet the needs of patients and advance clinical research. Our innovative technologies have the ability to fundamentally transform the ways that medical radioisotopes are produced and distributed around the world.

Learn More About NorthStar

Inside NorthStar

June 21, 2021

NorthStar Medical Technologies, LLC Announces Appointment of Frank Scholz, Ph.D., as Senior Vice President and Chief Operating Officer

BELOIT, Wis., June 21, 2021 – NorthStar Medical Technologies, LLC, a global innovator in the development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals, today announced the appointment of Frank Scholz, Ph.D.,

Press Releases

June 10, 2021

NorthStar Medical Radioisotopes Announces Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

BELOIT, Wis., June 10, 2021 – NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, being held in a virtual format from June 11 −15, 2021.

Press Releases

May 26, 2021

Monopar and NorthStar Announce Filing of Composition of Matter Patent Protecting MNPR-101 Radiotherapeutic

WILMETTE, Ill. and BELOIT, Wis., May 26, 2021 – Monopar Therapeutics Inc.

How Can We Help?

Questions about company, products, supply solutions, careers or anything else?